Risk factor analysis of thymoma resection and its value in guiding clinical treatment

BACKGROUND In this study, relationships between clinicopathologic characteristics and progression-free survival (PFS) of patients after thymomectomy were analyzed to provide valuable suggestions regarding the treatment of thymoma. METHODS Data from 187 thymoma patients undergoing surgery at Beijing Tongren Hospital between January 1, 2006, and December 31, 2015, were retrospectively reviewed. We explored the risk factors for PFS among sex, age, thymoma-associated MG, completeness of resection, histologic type and TNM stage, and investigated their interrelationship. RESULTS Among the 187 patients, 18 patients (9.63%) had tumor recurrence/metastasis, and all of whom had in situ recurrence or pleural metastasis, and most of them (10 of 18 patients) had MG symptoms that reappeared or were aggravated. Fifteen patients (8.02%) died, and myasthenic crisis was a leading cause. Based on Cox regression analysis, only age (HR = 3.16; 95% CI: 1.44-6.91; p = 0.004) and the completeness of resection (HR = 9.03; 95% CI: 2.58-31.55; p = 0.001) were independent risk factors for PFS. Furthermore, we found that the completeness of resection was related to the histologic type (p = 0.009) and TNM stage (p < 0.001) by Fisher's exact test. CONCLUSIONS The results of this cohort study remind us that we should pay attention to the reappearance or aggravation of MG after thymoma resection, because it is the leading cause of death and may indicate tumor progression. Furthermore, completeness of resection was related to the histologic type and TNM stage, but it was the independent risk factors of thymoma. Therefore, R0 resection is critical to the prognosis of thymoma.

[1]  A. Nicholson,et al.  The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What's new in thymic epithelial, germ cell and mesenchymal tumors? , 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  N. Girard,et al.  Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  Hyun-Sung Lee,et al.  A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma. , 2017, The Annals of thoracic surgery.

[4]  Jianxin Shi,et al.  Surgical treatment of thymoma: an 11-year experience with 761 patients. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  M. Ried,et al.  Extended Surgical Resections of Advanced Thymoma Masaoka Stages III and IVa Facilitate Outcome , 2013, Thoracic and Cardiovascular Surgeon.

[6]  F. Detterbeck,et al.  Thymoma: current diagnosis and treatment , 2013, Chinese medical journal.

[7]  S. Attaran,et al.  Which stages of thymoma benefit from adjuvant chemotherapy post-thymectomy? , 2012, Interactive cardiovascular and thoracic surgery.

[8]  T. Treasure,et al.  Rare thoracic cancers, including peritoneum mesothelioma. , 2012, European journal of cancer.

[9]  Y. Yoshioka,et al.  Postoperative radiation therapy after complete resection of thymoma has little impact on survival , 2009, Cancer.

[10]  K. Kondo Optimal therapy for thymoma. , 2008, The journal of medical investigation : JMI.

[11]  F. Detterbeck Clinical value of the WHO classification system of thymoma. , 2006, The Annals of thoracic surgery.

[12]  Woo Ick Yang,et al.  Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. , 2005, Chest.

[13]  L. Dogliotti,et al.  Multimodal management of stages III-IVa malignant thymoma. , 2004, Lung cancer.

[14]  F. Detterbeck,et al.  Thymic Tumors , 1989, The Annals of thoracic surgery.

[15]  N. Girard,et al.  Thymoma associated with autoimmune diseases: 85 cases and literature review. , 2016, Autoimmunity reviews.

[16]  W. Timens,et al.  Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. , 2008, European journal of cancer.

[17]  K. Kondo,et al.  Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. , 2005, The Annals of thoracic surgery.